Addiction

Shelby Blaes is the latest MBI Rising Star, a video series highlighting up-and-coming neuroscience researchers at UF.

Dr. Scott Teitelbaum and the Association of American Medical Colleges colleagues urged lawmakers to pass the Opioid Workforce Act. It would fund 1,000 new addiction medicine residencies, easing the shortage of physicians who specialize in the treatment of substance use disorder.

In The Conversation, Dr. Sara Jo Nixon discusses holiday drinking, how much is “too much,” and offers tactics for responsible drinking during celebratory times.

Addiction research led by Drs. Caitlin Orsini and Marcelo Febo, was recently chosen as a Research Highlight in the journal eNeuro.

FRC medical director and MBI member Dr. Scott Teitelbaum's personal journey helps him lead others to recovery.

MBI researcher Doug Miller discusses why people with HIV are more likely to develop neurological diseases and addiction in The Conversation.

An article by Dr. Scott Teitelbaum featured in The Conversation discusses the use of medication to treat addiction.

    Habibeh Khoshbouei, Pharm.D., Ph.D., associate professor of neuroscience in the MBI, explains her research into dopamine, a neurotransmitter involved in many brain-related functions.

The neurobehavioral sciences are gaining recognition for their potential to positively affect quality of life. Progress made in neuroscience has contributed new technologies to the armament of approaches for treating mental disorders. Research at the MBI New translational approaches include the development of pharmacological, electrical and behavioral therapies…